Filing Flows › Elite Pharmaceuticals (ELTP) › Licensing revenue
Elite Pharmaceuticals (ELTP) Licensing revenue by quarter
Elite Pharmaceuticals' Licensing revenue was $221K in Q1 FY27 (first quarter fiscal 2027), -25% from Q4 FY26. Over the last 7 quarters it ranged from $125K (Q2 FY26) to $626K (Q3 FY25).
| Quarter | Licensing revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $221K | -25% | -49% |
| Q4 FY26 | $296K | +44% | -29% |
| Q3 FY26 | $206K | +64% | -67% |
| Q2 FY26 | $125K | -71% | — |
| Q1 FY26 | $433K | +4% | — |
| Q4 FY25 | $417K | -33% | — |
| Q3 FY25 | $626K | — | — |
Q1 FY27 at a glance
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elite Pharmaceuticals' Licensing revenue?
Elite Pharmaceuticals' Licensing revenue was $221K in Q1 FY27 (first quarter fiscal 2027), -25% from Q4 FY26.
How has Elite Pharmaceuticals' Licensing revenue changed?
Over the last 7 quarters it ranged from $125K (Q2 FY26) to $626K (Q3 FY25).